PERRI MARKLE: Open Payments
NPI 1851164826 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$989 in 41 payments from 14 companies in 2025. Trend: 2023 $19 · 2024 $1,503 · 2025 $989
Food & beverage: $989
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $294 |
| Regeneron Healthcare Solutions, Inc. | 2 | $138 |
| EVOKE PHARMA, INC. | 1 | $110 |
| Janssen Scientific Affairs, LLC | 1 | $85 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $70 |
| Phathom Pharmaceuticals, Inc. | 5 | $62 |
| Madrigal Pharmaceuticals | 3 | $47 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $35 |
| Ardelyx, Inc. | 2 | $33 |
| GENZYME CORPORATION | 1 | $31 |
Products named: CREON, DUPIXENT, TREMFYA, GIMOTI, LINZESS, ENTYVIO, VOQUEZNA, REZDIFFRA.
Industry payments across PA — which companies pay providers there.
